ClassID:

112289

C12N2830/008 - page 5 - CPC Classification

Classification description:

Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Recent Application in this class:
#1201
20080166373
2008-07-10

METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS

#1202
20080160613
2008-07-03

Nonhuman model animal lacking the ability to control lymphocyte migration

#1203
20080153156
2008-06-26

Expression of factor IX in gene therapy vectors

#1204
20080152689
2008-06-26

DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS

#1205
20080145937
2008-06-19

In Vivo Transformation of Pancreatic Acinar Cells into Insulin-Producing Cells

#1206
20080134352
2008-06-05

Method for producing transgenic rats

#1207
20080131940
2008-06-05

Target Cell-Specific Short Interfering Rna and Methods of Use Thereof

#1208
20080125387
2008-05-29

Anemia

#1209
20080118470
2008-05-22

Oncolytic adenoviral vectors encoding GM-CSF

#1210
20080112929
2008-05-15

SHIELDED ADENOVIRAL VECTORS AND METHODS OF USE

#1211
20080108582
2008-05-08

Methods And Compositions For Combinatorial Approaches To Cancer Gene Therapy

#1212
20080103109
2008-05-01

Vectors for tissue-specific replication

#1213
20080096202
2008-04-24

Animal models for demyelination disorders

#1214
20080095747
2008-04-24

Promotion of Cell Migration and Axon Regeneration in the Cns

#1215
20080095744
2008-04-24

Methods and Compositions for Cytokine Expression and Treatment of Tumors

#1216
20080090279
2008-04-17

Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene

#1217
20080081354
2008-04-03

Devices, vectors and methods for inducible ischemia cardioprotection

#1218
20080076173
2008-03-27

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#1219
20080076172
2008-03-27

Vectors for tissue-specific replication

#1220
20080076145
2008-03-27

Transgenic flies expressing tau and amyloid precursor fragment

#1221
20080075740
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#1222
20080075737
2008-03-27

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor

#1223
20080070297
2008-03-20

REGULATORY ELEMENTS FOR DELIVERY TO THE LIVER

#1224
20080069791
2008-03-20

Means for stimulation and activation of hair growth by il-15

#1225
20080064862
2008-03-13

Transgene expression in a avians

#1226
20080063780
2008-03-13

Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion

#1227
20080060089
2008-03-06

Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom

#1228
20080052787
2008-02-28

Sale of fluorescent transgenic ornamental fish

#1229
20080051337
2008-02-28

Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them

#1230
20080050767
2008-02-28

Expression constructs expressing Prkag3

#1231
20080044393
2008-02-21

Retinal dystrophin transgene and methods of use thereof

#1232
20080038227
2008-02-14

Animal model of neurodegenerative diseases, the procedure for producing the model and applications thereof

#1233
20080032283
2008-02-07

TELOMELYSIN/GFP-EXPRESSING RECOMBINANT VIRUS

#1234
20080026459
2008-01-31

Isolation, selection and propagation of animal transgenic stem cells

#1235
20080019946
2008-01-24

Integration-type low-dose radiation-inducible vector

#1236
20080014583
2008-01-17

Methods for identifying candidate fat-mobilizing agents

#1237
20080008690
2008-01-10

AAV virions with decreased immunoreactivity and uses therefor

#1238
20080003682
2008-01-03

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

#1239
20080003658
2008-01-03

Method for expression of small antiviral RNA molecules within a cell

#1240
20070289029
2007-12-13

Means and methods for producing a stabilized cell of interest

#1241
20070287150
2007-12-13

Methods And Compositions Involving S-Ship Promoter Regions

#1242
20070286845
2007-12-13

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#1243
20070283451
2007-12-06

Protein kinase C iota

#1244
20070280908
2007-12-06

Treatment of diabetes with synthetic beta cells

#1245
20070275916
2007-11-29

Methods of Identifying Compounds Which Modulate Granulocite-Colony Stimulating Factor (G-Csf) Dependent Processes by Modulation of the Levels of Suppressor of Cytokine Signaling (Socs)

#1246
20070275376
2007-11-29

Tumor-Specific Expression of Reporter Genes

#1247
20070274971
2007-11-29

Method of Proliferating Precursor Cells

#1248
20070274923
2007-11-29

Non-invasive real-time in vivo bioluminescence imaging of local Ca2+ dynamics in living organisms

#1249
20070266451
2007-11-15

Transgenic animals producing low-lactose milk and newly identified human small intestinal extracellular lactase-phlorizin hydrolase (ecLPH) gene

#1250
20070264244
2007-11-15

Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease

#1251
20070259825
2007-11-08

Transgenic Mammals and Cell Lines for the Identification of Glutamate Transporter Modulators

#1252
20070259429
2007-11-08

Adenoviral vectors having a protein IX deletion

#1253
20070256147
2007-11-01

Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins

#1254
20070254357
2007-11-01

Gene therapy using replication competent targeted adenoviral vectors

#1255
20070253932
2007-11-01

RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE

#1256
20070250942
2007-10-25

Non-human transgenic mammals useful for identifying and assessing neural stem/progenitor cells

#1257
20070250941
2007-10-25

VEGF Receptor Conditional Knockout Animals and Methods of Use

#1258
20070244064
2007-10-18

Methods and compositions to induce antitumor response

#1259
20070243186
2007-10-18

ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof

#1260
20070243168
2007-10-18

Minigene expression cassette

#1261
20070243165
2007-10-18

Glycosylated G-CSF obtained from a transgenic chicken

#1262
20070238685
2007-10-11

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

#1263
20070238675
2007-10-11

Stem Cell Beacon

#1264
20070234444
2007-10-04

Floral transition genes in maize and uses thereof

#1265
20070234435
2007-10-04

Tie-2 driven overexpression of calreticulin as an inducer of non-small cell carcinoma of lung

#1266
20070225245
2007-09-27

Viral vector driven mutant bacterial cytosine deaminase gene and uses thereof

#1267
20070212779
2007-09-13

Targeting adenoviral vectors to dendritic cells

#1268
20070212334
2007-09-13

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

#1269
20070207167
2007-09-06

Immunologically enhanced recombinant vaccines

#1270
20070199079
2007-08-23

Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation

#1271
20070196922
2007-08-23

Methods and compositions relating to restricted expression lentiviral vectors and their applications

#1272
20070192880
2007-08-16

Horming response element binding transregulators

#1273
20070192879
2007-08-16

Transgenic non-human mammal

#1274
20070186300
2007-08-09

Transgenic mouse capable of over-expressing VE-PTP

#1275
20070180546
2007-08-02

Production of a transgenic avian by cytoplasmic injection

#1276
20070178592
2007-08-02

Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same

#1277
20070166367
2007-07-19

Adept or gdept producing acetaldehyde

#1278
20070166366
2007-07-19

Autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells

#1279
20070166286
2007-07-19

Self-rearranging DNA vectors

#1280
20070150974
2007-06-28

TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf-1 GENE

#1281
20070150971
2007-06-28

Sequences upstream of the carp gene, vectors containing them and uses thereof

#1282
20070148706
2007-06-28

Pancreatic progenitor cells and methods for isolating the same

#1283
20070141028
2007-06-21

Cancer gene therapeutic drug

#1284
20070134202
2007-06-14

Cancer gene therapeutic drug

#1285
20070130629
2007-06-07

Renal Regulatory Elements and Methods of Use Thereof

#1286
20070128166
2007-06-07

Adenoviral vectors having a protein IX deletion

#1287
20070124829
2007-05-31

Avians containing a lysozyme promoter transgene

#1288
20070122385
2007-05-31

Replication competent viruses capable of silencing virus inhibitory factor expression

#1289
20070117766
2007-05-24

Vigilant cells

#1290
20070113299
2007-05-17

Transgenic avians containing recombinant ovomucoid promoters

#1291
20070107076
2007-05-10

Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo

#1292
20070107072
2007-05-10

Transgenic amphibian models for lymphatic vessel development

#1293
20070107071
2007-05-10

Use of regulatory sequences for specific, transient expression in neuronal determined cells

#1294
20070092968
2007-04-26

hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

#1295
20070089177
2007-04-19

Transgenic animal and methods for decreasing cardiac cell death via cardiac-specific SIR2alpha overexpression

#1296
20070089175
2007-04-19

Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses

#1297
20070086985
2007-04-19

Vectors for tissue-specific replication

#1298
20070086982
2007-04-19

Gene therapy for regulating smooth muscle tone

#1299
20070077228
2007-04-05

Method of treating or retarding the development of blindness

#1300
20070077226
2007-04-05

Gutless adenovirus vector and the construction method thereof

#1301
20070072818
2007-03-29

Regulation of angiogenesis with zinc finger proteins

#1302
20070072172
2007-03-29

Liver specific chimeric regulatory sequence and use thereof

#1303
20070071724
2007-03-29

Peptide having hydrolase activity

#1304
20070067859
2007-03-22

Double-muscling in mammals

#1305
20070067855
2007-03-22

Production of human glycosylated proteins in transgenic insects

#1306
20070066552
2007-03-22

Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids

#1307
20070061909
2007-03-15

Transgenic mouse model and methods for treatment of neuro muscular disease by interfering with androgen-androgen receptor interaction in skeletal muscles

#1308
20070061908
2007-03-15

Methods of obtaining neural stem cells

#1309
20070059797
2007-03-15

Upstream control elements of the proopiomelanocortin gene and their use

#1310
20070059289
2007-03-15

Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with Hsp20

#1311
20070059287
2007-03-15

Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same

#1312
20070056051
2007-03-08

Expression system for insect pest control

#1313
20070054872
2007-03-08

REGULATABLE OR CONDITIONAL EXPRESSION SYSTEMS

#1314
20070044164
2007-02-22

Methods for producing microRNAs

#1315
20070037158
2007-02-15

Methods of modulating bone growth, bone remodeling and adiposity

#1316
20070036760
2007-02-15

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

#1317
20070036759
2007-02-15

Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same

#1318
20070032439
2007-02-08

Tarp promoter and uses thereof

#1319
20070031941
2007-02-08

Methods and compositions for expressing negative-sense viral RNA in canine cells

#1320
20070031392
2007-02-08

Delivery vehicle for recombinant proteins

#1321
20070031381
2007-02-08

Recombinant adenoviral vector and method of use

#1322
20070026445
2007-02-01

Steroid-activated nuclear receptors and uses therefor

#1323
20070022483
2007-01-25

Tau hyperphosphorylation in transgenic mice expressing the APP double mutation

#1324
20070020237
2007-01-25

Glucose inducible insulin expression and methods of treating diabetes

#1325
20070016968
2007-01-18

Treatment of pain through expression of opioid receptors

#1326
20070015198
2007-01-18

DNA sequence detection of nucleated red blood cells

#1327
20070011757
2007-01-11

Transgenic rodents as animal models for modulation of B1 bradykinin receptor protein

#1328
20070011755
2007-01-11

Diabetes type 2 animal model

#1329
20070011754
2007-01-11

Lysosomal proteins produced in the milk of transgenic animals

#1330
20070011752
2007-01-11

Production of human proteins in transgenic animal saliva

#1331
20070010016
2007-01-11

Gene transfer with adenoviruses having modified fiber proteins

#1332
20070009991
2007-01-11

Gene expression in transgenic avians

#1333
20070009486
2007-01-11

Adenoviral vectors having a protein IX deletion

#1334
20070006334
2007-01-04

Transgenic animals expressing salivary proteins

#1335
20070003518
2007-01-04

Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases

#1336
20060292609
2006-12-28

Interferon-beta gene therapy using an improved, regulated expression system

#1337
20060288436
2006-12-21

SCREENING SYSTEMS AND METHODS FOR IDENTIFYING MODULATORS OF XENOBIOTICMETABOLISM

#1338
20060288435
2006-12-21

CD9/CD81 double-deficient non-human animal

#1339
20060286591
2006-12-21

Methods and compositions for expressing negative-sense viral RNA in canine cells

#1340
20060286090
2006-12-21

Mediators of epithelial adhesion and their role in cancer and skin disorders

#1341
20060286083
2006-12-21

Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases

#1342
20060282905
2006-12-14

Animal models for demyelination disorders

#1343
20060281704
2006-12-14

Regulation of endogenous gene expression in cells using zinc finger proteins

#1344
20060276427
2006-12-07

Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins

#1345
20060275264
2006-12-07

Glutamic acid decarboxylase (GAD) chimera and methods of use

#1346
20060275262
2006-12-07

Conditionally replicating viruses and methods for cancer virotherapy

#1347
20060275261
2006-12-07

Adenoviral vectors having a protein IX deletion

#1348
20060265769
2006-11-23

Gab2 (p97) gene and methods of use thereof

#1349
20060259992
2006-11-16

Animal models of long QT syndrome and uses thereof

#1350
20060257369
2006-11-16

Therapeutic regimen for treating cancer

#1351
20060257367
2006-11-16

Tumour-cell specific gene expression and its use in cancer therapy

#1352
20060253913
2006-11-09

Production of hSA-linked butyrylcholinesterases in transgenic mammals

#1353
20060242725
2006-10-26

Cell-specific molecule and method for importing DNA into osteoblast nuclei

#1354
20060242717
2006-10-26

Expression systems

#1355
20060236415
2006-10-19

Neural crest cells specific promoters; isolated neural crest cells; and methods of isolating and of using same

#1356
20060236412
2006-10-19

Porcine uroplakin II promoter and the production method of useful proteins using said promoter

#1357
20060233759
2006-10-19

Adenoviral vectors having a protein IX deletion

#1358
20060233757
2006-10-19

Vectors with viral insulators

#1359
20060228776
2006-10-12

PINK-1 promoter

#1360
20060223141
2006-10-05

Transcription amplification system for molecular imaging

#1361
20060212957
2006-09-21

TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf GENE 1

#1362
20060206952
2006-09-14

Transgenic chickens

#1363
20060204478
2006-09-14

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#1364
20060200871
2006-09-07

Transgenic non-human animals with expanded mature b cell and plasma cell populations

#1365
20060195916
2006-08-31

Transgenic animal as a model for fibrotic diseases

#1366
20060188990
2006-08-24

Novel prostate tumor-specific promoter

#1367
20060188988
2006-08-24

Optimized high yield synthetic plasmids

#1368
20060188522
2006-08-24

Viral agents

#1369
20060188479
2006-08-24

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#1370
20060188478
2006-08-24

Glycosylated interferon α

#1371
20060185029
2006-08-17

Avians that produce eggs containing exogenous proteins

#1372
20060185024
2006-08-17

Production of exogenous proteins in egg whites of transgenic chickens

#1373
20060179500
2006-08-10

Methods and vectors for improving nucleic acid expression

#1374
20060179493
2006-08-10

Transgenically produced non-secreted proteins

#1375
20060177423
2006-08-10

Composition and method for killing of tumours

#1376
20060174363
2006-08-03

Germline transmission of avian primordial germ cells (PGCs)

#1377
20060174362
2006-08-03

Long-term culture of avian primordial germ cells (PGCs)

#1378
20060172297
2006-08-03

Enhancers specific to motor nerve cells/sensory nerve cells

#1379
20060171925
2006-08-03

Adenoviral vectors having a protein IX deletion

#1380
20060171921
2006-08-03

Glycosylated interferon alpha obtained from a transgenic chicken

#1381
20060168665
2006-07-27

Flourescent proteins as cell type specific reporters

#1382
20060165658
2006-07-27

Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof

#1383
20060165657
2006-07-27

Method for delivery of cosmetic by topical application

#1384
20060162001
2006-07-20

Mammalian grainyhead transcription factors

#1385
20060156420
2006-07-13

Malarial animal model having a chimeric human liver

#1386
20060148073
2006-07-06

Enhancement of adenoviral oncolytic activity by modification of the E1A gene product

#1387
20060141627
2006-06-29

Vectors for stable gene expression

#1388
20060140910
2006-06-29

Recombinant adenoviral vectors and methods of use

#1389
20060130169
2006-06-15

Transgenic non-human mammals as models for human pathologies of stem cell origin

#1390
20060130168
2006-06-15

Method of screening candidate drugs for the treatment of leukemia

#1391
20060130167
2006-06-15

Transgenic non-human mammals as models for human pathologies of stem cell origin

#1392
20060130166
2006-06-15

Transgenic non-human mammals as models for human pathologies of stem cell origin

#1393
20060128647
2006-06-15

Novel oligonucleotides and treating cardiac disorders by using the same

#1394
20060128018
2006-06-15

Directed genetic modifications of human stem cells

#1395
20060123488
2006-06-08

Method of producing an exogenous protein in the egg of a chicken

#1396
20060121013
2006-06-08

Use of negative regulatory elements for the neurospecific expression of transgenes

#1397
20060121000
2006-06-08

Methods and vectors for controlling gene expression

#1398
20060117398
2006-06-01

Suppression of endogenous immunoglobulin expression

#1399
20060115895
2006-06-01

Fish disease models and uses thereof

#1400
20060110377
2006-05-25

Immunologically privileged cells and uses thereof

#1401
20060110362
2006-05-25

Sequences upstream of the CARP gene, vectors containing them and uses thereof

#1402
20060105347
2006-05-18

Method for the production of fusion proteins in transgenic mammal milk

#1403
20060104954
2006-05-18

Recombinant adeno-associated virus virions for the treatment of lysosomal disorders

#1404
20060101532
2006-05-11

Methods for the identification of compounds for the treatment of Alzheimer's disease

#1405
20060101531
2006-05-11

Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene

#1406
20060099709
2006-05-11

Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors

#1407
20060099187
2006-05-11

Adenoviral vectors having a protein IX deletion

#1408
20060090214
2006-04-27

Method of treatment and an animal model useful for same

#1409
20060084618
2006-04-20

Adiponectin promoter and use thereof

#1410
20060080745
2006-04-13

Gene reactivation by somatic hypermutation

#1411
20060078878
2006-04-13

Regulation of endogenous gene expression in cells using zinc finger proteins

#1412
20060075513
2006-04-06

Transgenic chickens producing exogenous protein in eggs

#1413
20060070136
2006-03-30

GLYT1 transgenic mouse

#1414
20060070133
2006-03-30

Methods and compositions for importing nucleic acids into cell nuclei

#1415
20060068370
2006-03-30

Hepatoma specific chimeric regulatory sequence

#1416
20060067890
2006-03-30

Telomelysin/GFP-expressing recombinant virus

#1417
20060064768
2006-03-23

Murine Pten null prostate cancer model

#1418
20060064764
2006-03-23

Increasing gamete production with a gene switch

#1419
20060063709
2006-03-23

Nuclear factors associated with transcriptional regulation

#1420
20060063258
2006-03-23

Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders

#1421
20060059576
2006-03-16

Treatment of neurodegenerative conditions with nimesulide

#1422
20060058258
2006-03-16

Gene transcription and ionizing radiation: methods and compositions

#1423
20060057725
2006-03-16

Therapeutic retroviral vectors for gene therapy

#1424
20060057574
2006-03-16

Tissue specific expression

#1425
20060053504
2006-03-09

Tissue specific expression of exogenous proteins in transgenic chickens

#1426
20060051333
2006-03-09

AAV virions with decreased immunoreactivity and uses therefor

#1427
20060045873
2006-03-02

Induction of methylation of CpG sequences by dsRNAS in mammalian cells

#1428
20060039893
2006-02-23

Adenoviral vectors having a protein IX deletion

#1429
20060034804
2006-02-16

Adenoviral vectors having a protein IX deletion

#1430
20060029596
2006-02-09

Replication-competent anti-cancer vectors

#1431
20060029582
2006-02-09

Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy

#1432
20060026695
2006-02-02

Transgenically produced fusion proteins

#1433
20060024278
2006-02-02

Methods and products related to the production of inner ear hair cells

#1434
20060024273
2006-02-02

Target cell-specific adenoviral vectors containing E3 and methods of use thereof

#1435
20060019345
2006-01-26

Human GABAreceptor 1 promoters

#1436
20060019337
2006-01-26

Dual expression vector system and screening methods

#1437
20060018841
2006-01-26

AAV vectors for gene delivery to the lung

#1438
20060015960
2006-01-19

Method of making protein in an egg of a transgenic chicken

#1439
20060015959
2006-01-19

Transgenic animals expressing transglutaminase II

#1440
20060015948
2006-01-19

Zebrafish assay

#1441
20060009402
2006-01-12

In vivo production of small interfering RNAS that mediate gene silencing

#1442
20060003959
2006-01-05

Methods and agents for maintaining muscle mass and for preventing muscle atrophy and biomarkers for monitoring same

#1443
20060002897
2006-01-05

Vectors for tissue-specific replication

#1444
20060002895
2006-01-05

Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery

#1445
20050287120
2005-12-29

Cancer - targeted viral vectors

#1446
20050282280
2005-12-22

Oncolytic adenoviral vectors encoding GM-CSF

#1447
20050282231
2005-12-22

Hedgehog antibodies

#1448
20050281787
2005-12-22

Tumor-specific vector for gene therapy

#1449
20050277605
2005-12-15

Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation

#1450
20050276787
2005-12-15

Adeno-associated vector compositions for expression of Factor VIII

#1451
20050273874
2005-12-08

Method for producing heart-specific fluorescence of non-human eukaryotic animals

#1452
20050273873
2005-12-08

Genomic modification

#1453
20050273867
2005-12-08

Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms

#1454
20050272156
2005-12-08

System and method for electroporating a sample

#1455
20050271637
2005-12-08

BMP-2 estrogen responsive element and methods of using the same

#1456
20050267062
2005-12-01

Regulation of angiogenesis with zinc finger proteins

#1457
20050266549
2005-12-01

Molecular switch for regulating mammalian gene expression

#1458
20050265983
2005-12-01

Methods, nucleic acid constructs and cells for treating neurodegenerative disorders

#1459
20050265972
2005-12-01

Treatment of diabetes with synthetic beta cells

#1460
20050261234
2005-11-24

GFAP-based gene therapy for treatment of retinal diseases

#1461
20050257278
2005-11-17

Transgenic non-human animals expressing a truncated activin type II receptor

#1462
20050249752
2005-11-10

Vector for anti-HPV vaccine and transformed microorganism by the vector

#1463
20050246781
2005-11-03

Transgenic production in saliva

#1464
20050238624
2005-10-27

Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications

#1465
20050235371
2005-10-20

Merozoite surface protein 1 lacking glycosylation sites

#1466
20050235367
2005-10-20

Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof

#1467
20050235366
2005-10-20

Animal model, cells, and treatment for malignant melanoma

#1468
20050229262
2005-10-13

Peptide production

#1469
20050229261
2005-10-13

Transgenic mammal secreting B-domain deleted human FVII in its milk

#1470
20050227315
2005-10-13

Exogenous protein expression system in an avian system

#1471
20050221429
2005-10-06

Host cells containing multiple integrating vectors comprising an amplifiable marker

#1472
20050215507
2005-09-29

Therapeutic anti-cancer DNA

#1473
20050215502
2005-09-29

Regulation of endogenous gene expression in cells using zinc finger proteins

#1474
20050210540
2005-09-22

GLYT1 transgenic mouse

#1475
20050208533
2005-09-22

Modulators of morphogen expression and methods of identifying the same

#1476
20050208022
2005-09-22

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#1477
20050201984
2005-09-15

Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars

#1478
20050198698
2005-09-08

Production of recombinant polypeptides by bovine species and transgenic methods

#1479
20050198696
2005-09-08

Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders

#1480
20050196858
2005-09-08

Isolation, selection and propagation of animal transgenic stem cells

#1481
20050196751
2005-09-08

Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods

#1482
20050193433
2005-09-01

Compositions and methods of modulating cholesterol metabolism

#1483
20050191693
2005-09-01

Methods and cell populations for identifying and validating genomic targets, and for drug screening

#1484
20050188431
2005-08-25

Avians expressing heterologous protein

#1485
20050188430
2005-08-25

Transgenic avians and protein production

#1486
20050186179
2005-08-25

Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis

#1487
20050186178
2005-08-25

Oncolytic adenoviral vectors encoding GM-CSF

#1488
20050181428
2005-08-18

Polynucleotide

#1489
20050177884
2005-08-11

Chimeric nonhuman animal

#1490
20050177879
2005-08-11

Production of growth hormone in the milk of a transgenic bovine and methods of purification of the growth hormone from the milk

#1491
20050177878
2005-08-11

Transgenic bovine comprising human growth hormone in its serum and methods of making

#1492
20050176047
2005-08-11

Avian gene expression controlling regions

#1493
20050172348
2005-08-04

Transgenic mouse expressing Prkag3

#1494
20050169890
2005-08-04

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#1495
20050164392
2005-07-28

Accessory functions for use in recombinant AAV virion production

#1496
20050160482
2005-07-21

Assay for toxin induced neuronal degeneration and viability in

#1497
20050158310
2005-07-21

Methods and compositions for preventing obesity and obesity related disorders

#1498
20050158308
2005-07-21

HEH4 molecules and uses thereof

#1499
20050155097
2005-07-14

Eosinophil-deficient transgenic animals

#1500
20050155091
2005-07-14

Prkag3 gene promoter and uses thereof